Xiaojia Ni

1.4k total citations
65 papers, 1.0k citations indexed

About

Xiaojia Ni is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology. According to data from OpenAlex, Xiaojia Ni has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 14 papers in Pharmacology and 11 papers in Molecular Biology. Recurrent topics in Xiaojia Ni's work include Pharmacogenetics and Drug Metabolism (8 papers), Sleep and related disorders (7 papers) and Bipolar Disorder and Treatment (6 papers). Xiaojia Ni is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Sleep and related disorders (7 papers) and Bipolar Disorder and Treatment (6 papers). Xiaojia Ni collaborates with scholars based in China, United States and Australia. Xiaojia Ni's co-authors include Xinfeng Guo, Chuanjian Lu, Dewei Shang, Johannah Linda Shergis, Anthony Lin Zhang, Charlie Changli Xue, Haoyang Lu, Jinqing Hu, Shaonan Liu and Zhanzhang Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Osteoporosis International.

In The Last Decade

Xiaojia Ni

62 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojia Ni China 17 214 171 162 150 138 65 1.0k
Gary Asher United States 22 179 0.8× 338 2.0× 150 0.9× 141 0.9× 199 1.4× 40 1.6k
Fang Liu China 27 420 2.0× 365 2.1× 67 0.4× 253 1.7× 202 1.5× 161 2.0k
Rongjuan Guo China 16 255 1.2× 93 0.5× 77 0.5× 115 0.8× 77 0.6× 49 802
Giovanni Messina Italy 23 290 1.4× 57 0.3× 59 0.4× 260 1.7× 104 0.8× 63 1.7k
Lina Ma China 20 510 2.4× 156 0.9× 40 0.2× 85 0.6× 223 1.6× 58 1.8k
Haiyan Yin China 28 423 2.0× 314 1.8× 62 0.4× 129 0.9× 146 1.1× 96 2.0k
Johannah Linda Shergis Australia 19 312 1.5× 274 1.6× 139 0.9× 133 0.9× 49 0.4× 37 958
Khuen Yen Ng Malaysia 18 429 2.0× 69 0.4× 239 1.5× 147 1.0× 39 0.3× 54 1.4k
Ralf Uebelhack Germany 19 146 0.7× 118 0.7× 30 0.2× 92 0.6× 236 1.7× 69 1.2k

Countries citing papers authored by Xiaojia Ni

Since Specialization
Citations

This map shows the geographic impact of Xiaojia Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojia Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojia Ni more than expected).

Fields of papers citing papers by Xiaojia Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojia Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojia Ni. The network helps show where Xiaojia Ni may publish in the future.

Co-authorship network of co-authors of Xiaojia Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojia Ni. A scholar is included among the top collaborators of Xiaojia Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojia Ni. Xiaojia Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Yunlan, et al.. (2023). Efficacy of acupuncture for cardiopulmonary cerebral resuscitation: A systematic review and meta-analysis. Integrative Medicine Research. 12(1). 100925–100925. 1 indexed citations
3.
Ni, Xiaojia, et al.. (2023). The preliminary evidence on the association of the gut microbiota with stroke risk stratification in South Chinese population. Frontiers in Cellular and Infection Microbiology. 13. 1227450–1227450. 2 indexed citations
4.
Ren, Mengjuan, et al.. (2022). The role of acupuncture and moxibustion in the treatment, prevention, and rehabilitation of patients with COVID-19: A scoping review. Integrative Medicine Research. 11(4). 100886–100886. 9 indexed citations
5.
Liu, Shujing, Tao Xiao, Shanqing Huang, et al.. (2022). Population pharmacokinetics model for escitalopram in Chinese psychiatric patients: effect of CYP2C19 and age. Frontiers in Pharmacology. 13. 964758–964758. 6 indexed citations
6.
Li, Xiaolin, Shanqing Huang, Tao Xiao, et al.. (2022). Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients. Frontiers in Pharmacology. 13. 966622–966622. 8 indexed citations
7.
Zhu, Xiuqing, Jinqing Hu, Shuhua Deng, et al.. (2021). Comprehensive Bibliometric Analysis of the Kynurenine Pathway in Mood Disorders: Focus on Gut Microbiota Research. Frontiers in Pharmacology. 12. 687757–687757. 31 indexed citations
8.
9.
Jia, Lin, Qi Deng, Yuguan Wen, et al.. (2021). Role of serum amitriptyline concentration and CYP2C19 polymorphism in predicting the response to low-dose amitriptyline in irritable bowel syndrome. Digestive and Liver Disease. 53(11). 1422–1427. 1 indexed citations
10.
Luo, Xufei, Xiaojia Ni, Jiahui Lin, et al.. (2020). The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis. Phytomedicine. 85. 153282–153282. 47 indexed citations
11.
Ni, Xiaojia, Johannah Linda Shergis, Anthony Lin Zhang, et al.. (2018). Traditional Use of Chinese Herbal Medicine for Insomnia and Priorities Setting of Future Clinical Research. The Journal of Alternative and Complementary Medicine. 25(1). 8–15. 33 indexed citations
12.
Ni, Xiaojia, Zhanzhang Wang, Dewei Shang, et al.. (2018). Simultaneous analysis of olanzapine, fluoxetine, and norfluoxetine in human plasma using liquid chromatography-mass spectrometry and its application to a pharmacokinetic study. Journal of Chromatography B. 1092. 506–514. 24 indexed citations
13.
Xiao, Xiaolan, et al.. (2017). Tetramethylpyrazine Protects against Early Brain Injury after Experimental Subarachnoid Hemorrhage by Affecting Mitochondrial‐Dependent Caspase‐3 Apoptotic Pathway. Evidence-based Complementary and Alternative Medicine. 2017(1). 3514914–3514914. 11 indexed citations
14.
Hayes, Risa P., Xiaojia Ni, Darell Heiselman, & Kraig Kinchen. (2016). Psychometric testing of two new patient‐reported outcome instruments for the evaluation of treatment for hypogonadism. International Journal of Clinical Practice. 70(7). 587–595. 1 indexed citations
15.
Smith, Claire, Yan Jin, Eyas Raddad, et al.. (2016). Applications of Bayesian statistical methodology to success criteria: A case study of a phase 2 design with interim futility assessment in patients with knee osteoarthritis. Osteoarthritis and Cartilage. 24. S185–S185. 1 indexed citations
16.
Hu, Jinqing, Dewei Shang, Xiaojia Ni, et al.. (2015). Effect of grapefruit juice and food on the pharmacokinetics of pirfenidone in healthy Chinese volunteers: a diet–drug interaction study. Xenobiotica. 46(6). 516–521. 11 indexed citations
17.
He, Zehui, Chuanjian Lu, Mary‐Margaret Chren, et al.. (2014). Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health and Quality of Life Outcomes. 12(1). 190–190. 33 indexed citations
18.
Ni, Xiaojia, et al.. (2014). Efficacy and Safety of Tai Chi for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE. 9(6). e99377–e99377. 78 indexed citations
19.
Seftel, A D, et al.. (2012). Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs ⩾50 years. International Journal of Impotence Research. 25(3). 91–98. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Asher Breakdown of academic impact, for papers by Fang Liu Breakdown of academic impact, for papers by Rongjuan Guo Breakdown of academic impact, for papers by Giovanni Messina Breakdown of academic impact, for papers by Lina Ma Breakdown of academic impact, for papers by Haiyan Yin Breakdown of academic impact, for papers by Johannah Linda Shergis Breakdown of academic impact, for papers by Khuen Yen Ng Breakdown of academic impact, for papers by Ralf Uebelhack
Rankless by CCL
2026